<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Telomerase reactivation and expression of human telomerase gene [human telomerase reverse transcriptase (hTERT)] are hallmarks of unlimited proliferation potential of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>A polymorphic tandem repeats minisatellite of hTERT gene, termed MNS16A was reported to influence hTERT expression </plain></SENT>
<SENT sid="2" pm="."><plain>To assess the role of MNS16A as potential biomarker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), we investigated for the first time the association of MNS16A genotypes with risk of colorectal <z:mpath ids='MPATH_491'>polyps</z:mpath> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In the ongoing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> study of Austria (CORSA), 3842 Caucasian participants were recruited within a large screening project in the province Burgenland including 90 CRC cases, 308 high-risk <z:mpath ids='MPATH_491'>polyps</z:mpath>, 1022 low-risk <z:mpath ids='MPATH_491'>polyps</z:mpath> and 1822 <z:mpath ids='MPATH_491'>polyp</z:mpath> free controls verified by colonoscopy </plain></SENT>
<SENT sid="4" pm="."><plain>MNS16A genotypes were determined by polymerase chain reaction from genomic DNA </plain></SENT>
<SENT sid="5" pm="."><plain>Associations of MNS16A genotypes with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk were estimated by logistic regression analysis computing odds ratios (ORs) and 95% confidence intervals (CIs) </plain></SENT>
<SENT sid="6" pm="."><plain>We identified five different variable number of tandem repeats (VNTRs) of MNS16A including VNTR-364, a newly discovered rare variant </plain></SENT>
<SENT sid="7" pm="."><plain>VNTR-274 allele was associated with a 2.7-fold significantly increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> compared with the VNTR-302 <z:mp ids='MP_0002169'>wild-type</z:mp> (OR = 2.69; 95% CI = 1.11-6.50; P = 0.028) </plain></SENT>
<SENT sid="8" pm="."><plain>In our CORSA study, the medium length VNTR-274 was identified as risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Although, this population-based study herewith reports the largest cohort size concerning MNS16A thus far, further large-scale studies in diverse populations are warranted to confirm hTERT MNS16A genotype as potential biomarker for assessment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk </plain></SENT>
</text></document>